To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
NCCRED will fund clinical researchers through competitive grants totalling $1.8 million AUD. Two types of funding have been established over three funding rounds: Seed Funding Grants and Capacity Building Grants. All currently planned NCCRED funding rounds are closed. Stay tuned for further rounds.
NCCRED has established a seed funding research program. The seed funding grants aimed to develop evidence-based treatments and treatment models in response to prevalent, persistent and harmful emerging substances or methamphetamines. Grant recipients will contribute to the implementation of new and innovative treatment interventions. The funding will provide financial support as a seed-funding grant to establish investigator-initiated clinical trials / treatment research. The initial funding rounds specifically targeted those projects investigating treatment options for methamphetamine or emerging drugs of concern dependence / use disorder; with subsequent funding rounds broadening the scope to include any new or emerging drug of concern.
Applicants were encouraged to apply for funding that will answer clinical questions, build research capacity, and produce translational research results. The grant should produce a fundable project that could eventually attract further funding streams. Applications for the seed funding grants were reviewed by the NCCRED Methamphetamine and Emerging Drugs Working Group, and funding allocated by the NCCRED Board.
Non-renewable grants of $5,000-$100,000 will be awarded, with $500,000 of funding available.
For further information, please contact us.
1. What are Emerging Drugs?
The Australian Government Department of Health defines Emerging Drugs as:
New psychoactive drugs appearing on the market. They include novel drug classes which are potentially harmful. They also include new formulations of older drug classes for which problems related to their use are emerging. The situation is rapidly changing. There are hundreds of emerging drugs of concern, and this number is increasing every year.
2. What does NCCRED mean by substantive?
By using this term, we mean to say that your project should be able to provide results that are clinically meaningful, and are translatable to clinical care. Even small projects can deliver important results, and have substantive impacts!
3. What constitutes a meaningful partnership?
NCCRED encourages applicants to develop and build on partnerships. This includes meaningful involvement in the grant application and execution of the research. For example, not just listing a partner as a site, but working with them to ensure they provide meaningful contribution to the research proposal and conduct.
4. What should be included in the data dissemination plan?
It is anticipated that all successful applicants will present results (interim or final) at the NCCRED Annual Research Symposium. The Symposium will be held as a day-long meeting sponsored by NCCRED and co-located with the APSAD conference (e.g. prior to or following the APSAD meeting in the same city/State)
All applicants are encouraged to ensure that attendance for presenting the project at the Symposium is within scope of the application’s budget
In addition, the budget should include peer-reviewed publication costs (e.g. open-access publishing fees)
The dissemination plan’s budget should not exceed $5,000
5. What is out of scope within the budget?
NCCRED cannot fund infrastructure (e.g. electricity or rent) to conduct the research outlined in your proposal.
6. Can I budget on-costs or institutional overheads into my application?
On-costs for salaried positions are acceptable, however; infrastructure fees for the grant monies (i.e. placed by an institution on research funds) are not permitted as the funding is sourced from the Australian Commonwealth Department of Health
7. Can NCCRED assist with developing my research proposal?
NCCRED offers mentoring internally and may be able to link you to an external mentor, to assist with conceptualising your research proposal and developing an application that will attract funding.
NCCRED encourages partnerships (e.g. clinician, academic, and consumer). It can be daunting to seek out partnership opportunities, and NCCRED recognises this. Contact NCCRED to see if there are opportunities for Knowledge Exchange Days that you may be able to participate in. We may also be able to link you to organisations that are actively seeking partnerships. We may be able to link you to someone appropriate, or generate other potential possibilities for you to consider. Feel free to get in touch!
8. What is the length / duration of the grant?
Round 2 Seed Funding Grants are required to submit a final report to NCCRED within 18 months (i.e. December 2020).
Round 3 Seed Funding are required to submit a final report to NCCRED within 18 months (i.e. April 2021).
9. What is a clinician?
The Australian Institute of Health and Welfare defines a clinician as:
A practitioner who spends most of their total weekly working hours engaged in clinical practice (that is, in diagnosis and/or treatment of patients including recommending preventive action) is classified as a ‘clinician’. A clinician may work clinical and non-clinical hours. – Australian Institute of Health and Welfare
10. What is clinical research?
The NHMRC has described Clinical Research as:
“a range of different health professionals studying a wide range of matters, including disease prevention and causation, diagnostic methods, treatments, and effects of and response to illness. Such research can occur in a number of settings, including public and private hospitals and clinics, other institutions or organisations, community settings, and general or specialist medical practices”.
In this keeping, NCCRED aims to facilitate clinical research, through the conduct, mentoring and dissemination of clinical trials, epidemiological studies, behavioural studies and other research methodologies relevant to the emerging drugs of concern research community.
Below is the list of Grants that have been awarded by NCCRED thus far. These grants were recommended for funding by the NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group (WG) and approved by the NCCRED Board.
Round 1 Capacity Building Grants
Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project
Grant Holder: Professor Nicholas Lintzeris, Director Drug & Alcohol Services, South East Sydney Local Health District
South Australian Drug Early Warning System – Emergency Department Admission Blood Psychoactive Testing
Grant Holder: Doctor Peter Stockham, Principal Forensic Scientist, Toxicology, Forensic Science SA
The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence
Grant Holder: Professor Paul Haber, Clinical Director, Drug Health Services, Sydney Local Health District, Royal Prince Alfred Hospital
Round 1 Seed Funding Grants
Emerging Drug Network of Australia (EDNA)
Grant Holder: Doctor Jessamine Soderstrom, Clinical Toxicologist, Royal Perth Hospital
Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views
Grant Holder: Doctor Briony Larance, Senior Research Fellow, University of Wollongong
Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service
Grant Holder: Doctor Craig Rodgers, Senior Staff Specialist, St Vincent’s Hospital Sydney
Round 2 Seed Funding Grants
An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings
Grant Holder: Associate Professor James Ward, Matthew Flinders Fellow- Flinders University, Head of Infectious Diseases Research- Aboriginal Health, Infection and Immunity Theme, South Australian Health and Medical Research Institute
An Open-Label Pilot Study of Subanesthetic Ketamine for Methamphetamine Abuse in Young People
Grant Holder: Doctor Gillinder Bedi, Senior Research Fellow – Addiction and Youth Mental Health, Orygen the National Centre of Excellence in Youth Mental Health
A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder
Grant Holder: Associate Professor Victoria Manning, Head of Research and Workforce Development, Turning Point
Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips
Grant Holder: Doctor Rachel Sutherland, Research Fellow, National Drug and Alcohol Research Centre
Methamphetamine and mutual support: A mixed methods exploration of SMART Recovery participants’ characteristics and opportunities for enhanced referral pathways
Grant Holder: Associate Professor Peter Kelly, Head of Research, School of Psychology, University of Wollongong
Round 3 Seed Funding Grants
Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health
Grant Holder: Doctor Monica Barratt, Vice Chancellor’s Senior Research Fellow, Royal Melbourne Institute of Technology
Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence
Grant Holder: Professor Antonio Verdejo-Garcia, Addiction and Mental Health Program, Monash University
Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study.
Grant Holder: Professor Andrew Dawson, Clinical Professor of Addiction Medicine, Sydney Medical School, University of Sydney
BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine
Grant Holder: Associate Professor Peter Kelly, Head of Research, School of Psychology, University of Wollongong
Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems
Grant Holder: Associate Professor Suzanne Nielson, Associate Professor & Deputy Director, Monash Addiction Research Centre, Monash University
An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women
Grant Holder: Doctor Shalini Arunogiri, Addiction Psychiatrist, Clinical Lead- Turning Point Statewide Services, Eastern Health
Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts
Grant Holder: Doctor Amy Peacock, Senior Research Fellow, University of New South Wales
The WG, as a part of the NCCRED Clinical Research Network, is an independent group made up of core Australian researchers which the NCCRED staff and Board are not involved in. If you would like more information on the NCCRED Clinical Research Network or the NCCRED Board.